Search Results - "Muñoz Torrico, M"

Tuberculosis, social determinants and co-morbidities (including HIV) by Duarte, R, Lönnroth, K, Carvalho, C, Lima, F, Carvalho, A.C.C, Muñoz-Torrico, M, Centis, R

“…AbstractThe risk of exposure, progression to active tuberculosis (TB) and then to cure is a process affected by several risk factors. Along with well known…”
Get full text

New drugs and perspectives for new anti-tuberculosis regimens by Tiberi, S, Muñoz-Torrico, M, Duarte, R, Dalcolmo, M, D’Ambrosio, L, Migliori, G.-B

“…AbstractTuberculosis (TB) continues to cause more deaths worldwide than any other infectious disease. Even though global TB incidence has been decreasing for…”
Get full text

The need for pulmonary rehabilitation following tuberculosis treatment by Visca, D., Centis, R., D'Ambrosio, L., Muñoz-Torrico, M., Chakaya, J. Muhwa, Tiberi, S., Spanevello, A., Sotgiu, G., Migliori, G. B.

Get full text

Functional impact of sequelae in drug-susceptible and multidrug-resistant tuberculosis by Muñoz-Torrico, M., Cid-Juárez, S., Gochicoa-Rangel, L., Torre-Bouscolet, L., Salazar-Lezama, M. A., Villarreal-Velarde, H., Pérez-Padilla, R., Visca, D., Centis, R., D'Ambrosio, L., Spanevello, A., Saderi, L., Sotgiu, G., Migliori, G. B.

“…BACKGROUND: Evidence on the impact of tuberculosis (TB) treatment on lung function is scarce. The aim of this study was to evaluate post-treatment sequelae in…”
Get full text

Isoniazid-resistant TB: treatment outcomes and impact of regimens with fluoroquinolones by Silva, D. R., Muñoz-Torrico, M., Fernandes, G. R., Narvaez-Diaz, L., Miranda-Perez, A., dos Santos, A. P. C., Becerril-Vargas, E., Soto-Vidal, G., Willers, D. M. C., Migliori, G. B.

Get full text

Novel role for IL-22 in protection during chronic Mycobacterium tuberculosis HN878 infection by Treerat, P, Prince, O, Cruz-Lagunas, A, Muñoz-Torrico, M, Salazar-Lezama, M A, Selman, M, Fallert-Junecko, B, Reinhardt, T A, Alcorn, J F, Kaushal, D, Zuñiga, J, Rangel-Moreno, J, Kolls, J K, Khader, S A

“…Approximately 2 billion people are infected with Mycobacterium tuberculosis ( Mtb ), resulting in 1.4 million deaths every year. Among Mtb -infected…”
Get full text

Comparison of bacteriological conversion and treatment outcomes among MDR-TB patients with and without diabetes in Mexico: Preliminary data by Muñoz-Torrico, M, Caminero Luna, J, Migliori, G.B, D’Ambrosio, L, Carrillo-Alduenda, J.L, Villareal-Velarde, H, Torres-Cruz, A, Flores-Ergara, H, Martínez-Mendoza, D, García-Sancho, C, Centis, R, Salazar-Lezama, M.Á, Pérez-Padilla, R

“…AbstractDiabetes mellitus (DM) is a well-known risk factor for tuberculosis (TB). However, it is not known to what extent DM affects the outcome in patients…”
Get full text

Clinical standards for the assessment, management and rehabilitation of post-TB lung disease by Migliori, G. B., Marx, F. M., Ambrosino, N., Zampogna, E., Schaaf, H. S., van der Zalm, M. M., Allwood, B., Byrne, A. L., Mortimer, K., Wallis, R. S., Fox, G. J., Leung, C. C., Chakaya, J. M., Seaworth, B., Rachow, A., Marais, B. J., Furin, J., Akkerman, O. W., Al Yaquobi, F., Amaral, A. F. S., Borisov, S., Caminero, J. A., Carvalho, A. C. C., Chesov, D., Codecasa, L. R., Teixeira, R. C., Dalcolmo, M. P., Datta, S., Dinh-Xuan, A-T., Duarte, R., Evans, C. A., García-García, J-M., Günther, G., Hoddinott, G., Huddart, S., Ivanova, O., Laniado-Laborín, R., Manga, S., Manika, K., Mariandyshev, A., Mello, F. C. Q., Mpagama, S. G., Muñoz-Torrico, M., Nahid, P., Ong, C. W. M., Palmero, D. J., Piubello, A., Pontali, E., Silva, D. R., Singla, R., Spanevello, A., Tiberi, S., Udwadia, Z. F., Vitacca, M., Centis, R., D´Ambrosio, L., Sotgiu, G., Lange, C., Visca, D.

“…BACKGROUND: Increasing evidence suggests that post-TB lung disease (PTLD) causes significant morbidity and mortality. The aim of these clinical standards is to…”
Get full text

Clinical standards for drug-susceptible pulmonary TB by Akkerman, O. W., Duarte, R., Tiberi, S., Schaaf, H. S., Lange, C., Alffenaar, J. W. C., Denholm, J., Carvalho, A. C. C., Bolhuis, M. S., Borisov, S., Bruchfeld, J., Cabibbe, A. M., Caminero, J. A., Carvalho, I., Chakaya, J., Centis, R., Dalcomo, M. P., D´Ambrosio, L., Dedicoat, M., Dheda, K., Dooley, K. E., Furin, J., García-García, J-M., van Hest, N. A. H., de Jong, B. C., Kurhasani, X., Märtson, A. G., Mpagama, S., Torrico, M. Munoz, Nunes, E., Ong, C. W. M., Palmero, D. J., Ruslami, R., Saktiawati, A. M. I., Semuto, C., Silva, D. R., Singla, R., Solovic, I., Srivastava, S., de Steenwinkel, J. E. M., Story, A., Sturkenboom, M. G. G., Tadolini, M., Udwadia, Z. F., Verhage, A. R., Zellweger, J. P., Migliori, G. B.

“…BACKGROUND: The aim of these clinical standards is to provide guidance on 'best practice´ for diagnosis, treatment and management of drug-susceptible pulmonary…”
Get full text

Clinical standards for the management of adverse effects during treatment for TB by Singh, K. P., Carvalho, A. C. C., Centis, R., D´Ambrosio, L., Migliori, G. B., Mpagama, S. G., Nguyen, B. C., Aarnoutse, R. E., Aleksa, A., van Altena, R., Bhavani, P. K., Bolhuis, M. S., Borisov, S., van´t Boveneind-Vrubleuskaya, N., Bruchfeld, J., Caminero, J. A., Carvalho, I., Cho, J. G., Davies Forsman, L., Dedicoat, M., Dheda, K., Dooley, K., Furin, J., García-García, J. M., Garcia-Prats, A., Hesseling, A. C., Heysell, S. K., Hu, Y., Kim, H. Y., Manga, S., Marais, B. J., Margineanu, I., Märtson, A-G., Munoz Torrico, M., Nataprawira, H. M., Nunes, E., Ong, C. W. M., Otto-Knapp, R., Palmero, D. J., Peloquin, C. A., Rendon, A., Rossato Silva, D., Ruslami, R., Saktiawati, A. M. I., Santoso, P., Schaaf, H. S., Seaworth, B., Simonsson, U. S. H., Singla, R., Skrahina, A., Solovic, I., Srivastava, S., Stocker, S. L., Sturkenboom, M. G. G., Svensson, E. M., Tadolini, M., Thomas, T. A., Tiberi, S., Trubiano, J., Udwadia, Z. F., Verhage, A. R., Vu, D. H., Akkerman, O. W., Alffenaar, J. W. C., Denholm, J. T.

“…BACKGROUND: Adverse effects (AE) to TB treatment cause morbidity, mortality and treatment interruption. The aim of these clinical standards is to encourage…”
Get full text

Team approach to manage difficult-to-treat TB cases: Experiences in Europe and beyond by D’Ambrosio, L, Bothamley, G, Caminero Luna, J.A, Duarte, R, Guglielmetti, L, Muñoz Torrico, M, Payen, M.C, Saavedra Herrera, N, Salazar Lezama, M.A, Skrahina, A, Tadolini, M, Tiberi, S, Veziris, N, Migliori, G.B

“…AbstractAs recommended by the World Health Organization (WHO), optimal management of MDR-TB cases can be ensured by a multi-speciality consultation body known…”
Get full text

Post-tuberculosis sequelae: the need to look beyond treatment outcome by Visca, D., Centis, R., Munoz-Torrico, M., Pontali, E.

Get full text

Clinical standards for the dosing and management of TB drugs by Alffenaar, J. W. C., Stocker, S. L., Forsman, L. Davies, Garcia-Prats, A., Heysell, S. K., Aarnoutse, R. E., Akkerman, O. W., Aleksa, A., van Altena, R., de Oñata, W. Arrazola, Bhavani, P. K., van't Boveneind-Vrubleuskaya, N., Carvalho, A. C. C., Centis, R., Chakaya, J. M., Cirillo, D. M., Cho, J. G., D´Ambrosio, L., Dalcolmo, M. P., Denti, P., Dheda, K., Fox, G. J., Hesseling, A. C., Kim, H. Y., Köser, C. U., Marais, B. J., Margineanu, I., Märtson, A. G., Torrico, M. Munoz, Nataprawira, H. M., Ong, C. W. M., Otto-Knapp, R., Peloquin, C. A., Silva, D. R., Ruslami, R., Santoso, P., Savic, R. M., Singla, R., Svensson, E. M., Skrahina, A., van Soolingen, D., Srivastava, S., Tadolini, M., Tiberi, S., Thomas, T. A., Udwadia, Z. F., Vu, D. H., Zhang, W., Mpagama, S. G., Schön, T., Migliori, G. B.

“…BACKGROUND: Optimal drug dosing is important to ensure adequate response to treatment, prevent development of drug resistance and reduce drug toxicity. The aim…”
Get full text

Prospective evaluation of improving fluoroquinolone exposure using centralised therapeutic drug monitoring (TDM) in patients with tuberculosis (PERFECT): a study protocol of a prospective multicentre cohort study by van den Elsen, Simone HJ, Sturkenboom, Marieke GG, Akkerman, Onno, Barkane, Linda, Bruchfeld, Judith, Eather, Geoffrey, Heysell, Scott K, Hurevich, Henadz, Kuksa, Liga, Kunst, Heinke, Kuhlin, Johanna, Manika, Katerina, Moschos, Charalampos, Mpagama, Stellah G, Muñoz Torrico, Marcela, Skrahina, Alena, Sotgiu, Giovanni, Tadolini, Marina, Tiberi, Simon, Volpato, Francesca, van der Werf, Tjip S, Wilson, Malcolm R, Zúñiga, Joaquin, Touw, Daan J, Migliori, Giovanni B, Alffenaar, Jan-Willem

“…IntroductionGlobal multidrug-resistant tuberculosis (MDR-TB) treatment success rates remain suboptimal. Highly active WHO group A drugs moxifloxacin and…”
Get full text

Outcome of treatment of MDR-TB or drug-resistant patients treated with bedaquiline and delamanid: Results from a large global cohort by Koirala, S., Borisov, S., Danila, E., Mariandyshev, A., Shrestha, B., Lukhele, N., Dalcolmo, M., Shakya, S.R., Miliauskas, S., Kuksa, L., Manga, S., Aleksa, A., Denholm, J.T., Khadka, H.B., Skrahina, A., Diktanas, S., Ferrarese, M., Bruchfeld, J., Koleva, A., Piubello, A., Koirala, G.S., Udwadia, Z.F., Palmero, D.J., Munoz-Torrico, M., GC, R., Gualano, G., Grecu, V.I., Motta, I., Papavasileiou, A., Li, Y., Hoefsloot, W., Kunst, H., Mazza-Stalder, J., Payen, M.-C., Akkerman, O.W., Bernal, E., Manfrin, V., Matteelli, A., Mustafa Hamdan, H., Nieto Marcos, M., Cadiñanos Loidi, J., Cebrian Gallardo, J.J., Duarte, R., Escobar Salinas, N., Gomez Rosso, R., Laniado-Laborín, R., Martínez Robles, E., Quirós Fernandez, S., Rendon, A., Solovic, I., Tadolini, M., Viggiani, P., Belilovski, E., Boeree, M.J., Cai, Q., Davidavičienė, E., Forsman, L.D., De Los Rios, J., Drakšienė, J., Duga, A., Elamin, S.E., Filippov, A., Garcia, A., Gaudiesiute, I., Gavazova, B., Gayoso, R., Gruslys, V., Jonsson, J., Khimova, E., Madonsela, G., Magis-Escurra, C., Marchese, V., Matei, M., Moschos, C., Nakčerienė, B., Nicod, L., Palmieri, F., Pontarelli, A., Šmite, A., Souleymane, M.B., Vescovo, M., Zablockis, R., Zhurkin, D., Alffenaar, J.-W., Caminero, J.A., Codecasa, L.R., García-García, J.-M., Esposito, S., Saderi, L., Spanevello, A., Visca, D., Tiberi, S., Pontali, E., Centis, R., D'Ambrosio, L., van den Boom, M., Sotgiu, G., Migliori, G.B.

“…The World Health Organization (WHO) recommends countries introduce new anti-TB drugs in the treatment of multidrug-resistant tuberculosis. The aim of the study…”
Get full text

A numerical assesment of the effect of MRI surface coils on implanted pacemakers by Fontana, N., Monorchio, A., Torrico, M. O. Munoz, Yang Hao

“…Electromagnetic interaction between a radio frequency surface coil for magnetic resonance imaging (MRI) and a heterogeneous human model implanted with a…”
Get full text